Sign in

CIK 0001213037

  • Non-accelerated filer
  • Smaller reporting company

Cardiff Oncology, Inc.

Sign in to watch
Ticker
CRDF
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
272004382
Phone
+1 858-952-7570
Business address
11055 FLINTKOTE AVENUE, SAN DIEGO, CA, 92121
Former names
Trovagene, Inc., TrovaGene Inc., XENOMICS INC, USED KAR PARTS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 65 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-04-16 Armitage James O Director Grant or award · Stock Options +11,916 11,916
2020-04-16 White Lale Director Grant or award · Stock Options +11,916 11,916
2020-01-03 Erlander Mark Chief Scientific Officer Shares withheld for taxes −116 6,376
2020-01-03 Erlander Mark Chief Scientific Officer Shares withheld for taxes −552 6,231
2020-01-02 Erlander Mark Chief Scientific Officer Exercise or conversion +261 6,492
2020-01-02 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −261 260
2020-01-01 Erlander Mark Chief Scientific Officer Exercise or conversion +1,250 6,783
2020-01-01 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,250 521
2019-10-01 Erlander Mark Chief Scientific Officer Exercise or conversion +1,250 5,999
2019-10-01 Erlander Mark Chief Scientific Officer Shares withheld for taxes −466 5,533
2019-10-01 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,250 1,771
2019-07-01 Erlander Mark Chief Scientific Officer Exercise or conversion +1,250 5,210
2019-07-01 Erlander Mark Chief Scientific Officer Shares withheld for taxes −461 4,749
2019-07-01 Erlander Mark Chief Scientific Officer Exercise or conversion · Restricted Stock Units −1,250 3,021
2019-06-20 JACOB GARY S Director Grant or award · Stock Options +44,734 48,071
2019-06-20 ADAMS THOMAS PHD Chief Executive Officer Grant or award · Stock Options +298,230 304,725
2019-06-20 Markin Rodney S Director Grant or award · Stock Options +44,734 46,969
2019-06-20 Erlander Mark Chief Scientific Officer Grant or award · Stock Options +134,203 158,959
2019-06-20 Countouriotis Athena Director Grant or award · Stock Options +44,734 46,019
2019-06-20 BRANCACCIO JOHN P Director Grant or award · Stock Options +44,734 47,806

Page 9 of 15 · 299 trades